Michiko Nagashima-Hayashi

Ms. Michiko Nagashima-Hayashi

National University of Singapore
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Global Health Action
Verified
Journal Article
Open access
ADAnna Durrance-Bagale
Anna Durrance-Bagale
MMManar Marzouk
Manar Marzouk
LTLam Sze Tung
Lam Sze Tung
SASunanda Agarwal
Sunanda Agarwal
ZAZeenathnisa Mougammadou Aribou
Zeenathnisa Mougammadou Aribou
NHNatasha Howard
Natasha Howard
Healthcare research, planning, and delivery with minimal community engagement can result in financial wastage, failure to meet objectives, and frustration in the communities that programmes are des...

19 June 2023 in Conflict and Health
Verified
Journal Article
Open access
PDF file
MMManar Marzouk
Manar Marzouk
ADAnna Durrance-Bagale
Anna Durrance-Bagale
SLSze Tung Lam
Sze Tung Lam
MNMichiko Nagashima-Hayashi
Michiko Nagashima-Hayashi
MUMengieng Ung
Mengieng Ung
NHNatasha Howard
Natasha Howard
Introduction: Strengthening health systems in conflict-affected settings has become increasingly professionalised. However, evaluation remains challenging and often insufficiently documented in the literature. Many, particularly small-scale health system evaluations, are conducted by government bodies or non-governmental organisations (NGO) with limited capacity to publish their experiences. It is essential to identify the existing literature and main findings as a baseline for future efforts to evaluate the capacity and resilience of conflict-affected health systems. We thus aimed to synthesise the scope of methodological approaches and methods used in the peer-reviewed literature on health system evaluation in conflict-affected settings. Methods: We conducted a scoping review using Arksey and O’Malley’s method and synthesised findings using the WHO health system ‘building blocks’ framework. Results: We included 58 eligible sources of 2,355 screened, which included examination of health systems or components in 26 conflict-affected countries, primarily South Sudan and Afghanistan (7 sources each), Democratic Republic of the Congo (6), and Palestine (5). Most sources (86%) were led by foreign academic institutes and international donors and focused on health services delivery (78%), with qualitative designs predominating (53%). Theoretical or conceptual grounding was extremely limited and study designs were not generally complex, as many sources (43%) were NGO project evaluations for international donors and relied on simple and lower-cost methods. Sources were also limited in terms of geography (e.g., limited coverage of the Americas region), by component (e.g., preferences for specific components such as service delivery), gendered (e.g., limited participation of women), and colonised (e.g., limited authorship and research leadership from affected countries). Conclusion: The evaluation literature in conflict-affected settings remains limited in scope and content, favouring simplified study designs and methods, and including those components and projects implemented or funded internationally. Many identified challenges and limitations (e.g., limited innovation/contextualisation, poor engagement with local actors, gender and language biases) could be mitigated with more rigorous and systematic evaluation approaches.

MNMichiko Nagashima-Hayashi
Michiko Nagashima-Hayashi
ADAnna Durrance-Bagale
Anna Durrance-Bagale
MMManar Marzouk
Manar Marzouk
MUMengieng Ung
Mengieng Ung
SLSze Tung Lam
Sze Tung Lam
NHNatasha Howard
Natasha Howard
Since the early stages of the COVID-19 pandemic, there have been reports of increased violence against women globally. We aimed to explore factors associated with reported increases in gender-based violence (GBV) during the pandemic in the Asia-Pacific region. We conducted 47 semi-structured interviews with experts working in sexual and reproductive health in 12 countries in the region. We analysed data thematically, using the socio-ecological framework of violence. Risks associated with increased GBV included economic strain, alcohol use and school closures, together with reduced access to health and social services. We highlight the need to address heightened risk factors, the importance of proactively identifying instances of GBV and protecting women and girls through establishing open and innovative communication channels, along with addressing underlying issues of gender inequality and social norms. Violence is exacerbated during public health crises, such as the COVID-19 pandemic. Identifying and supporting women at risk, as well as preventing domestic violence during lockdowns and movement restrictions is an emerging challenge. Our findings can help inform the adoption of improved surveillance and research, as well as innovative interventions to prevent violence and detect and protect victims.

1 January 2005 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
YNYasuhide Nakayama
Yasuhide Nakayama
TMTakeshi Masuda
Takeshi Masuda
MNMakoto Nagaishi
Makoto Nagaishi
MNMichiko Nagashima-Hayashi
Michiko Nagashima-Hayashi
MOMoto Ohira
Moto Ohira
MHMariko Harada-Shiba
Mariko Harada-Shiba
Nano-structured hyperbranched cationic star polymers, called star vectors, were molecularly designed for a novel gene delivery non-viral vector. The linear and 3, 4 or 6 branched water-soluble cationic polymers, which had same molecular weight of ca. 18,000, were synthesized by iniferter (initiator-transfer agent-terminator)-based photo-livingradical polymerization of 3-(N,N-dimethylamino)propyl acrylamide, initiated from respective multi-dithiocarbamatederivatized benzenes as an iniferter. All polymers produced polyion complexes polyplexes by mixing with pDNA (pGL3-control plasmid), in which the particle size was ca. 250 nm in diameter [the charge ratio < 2 / 1 (vevtor / pDNA)] and ca. 150 nm (the charge ratio > 2.5 / 1), and the ζ-potential was ca. +10 mV (the charge ratio > 1 / 1). When COS-1 cells were incubated with the polyplexes 12h after preparation under the charge ratio of 5 / 1, higher gene expression was obtained as an increase in branching, with a little cytotoxicity. The relative gene expression to the linear polymer was about 2, 5, and 10 times in 3-, 4-, and 6-branched polymers, respectively. The precise change in branching of polymers enabled the control of the gene transfer activity.

26 December 2021 in International Journal of Health Policy and Management
Verified
Journal Article
Open access
ADAnna Durrance-Bagale
Anna Durrance-Bagale
MMManar Marzouk
Manar Marzouk
SASunanda Agarwal
Sunanda Agarwal
AAAparna Ananthakrishnan
Aparna Ananthakrishnan
SGSarah Gan
Sarah Gan
NHNatasha Howard
Natasha Howard
Background: The rapid spread of the coronavirus disease 2019 (COVID-19) pandemic demonstrates the value of regional cooperation in infectious disease prevention and control. We explored the literature on regional infectious disease control bodies, to identify lessons, barriers and enablers to inform operationalisation of a regional infectious disease control body or network in southeast Asia. Methods: We conducted a scoping review to examine existing literature on regional infectious disease control bodies and networks, and to identify lessons that can be learned that will be useful for operationalisation of a regional infectious disease control body such as the Association of Southeast Asian Nations (ASEAN) Center for Public Health Emergency and Emerging Diseases. Results: Of the 57 articles included, 53 (93%) were in English, with two (3%) in Spanish and one (2%) each in Dutch and French. Most were commentaries or review articles describing programme initiatives. Sixteen (28%) publications focused on organisations in the Asian continent, with 14 (25%) focused on Africa, and 14 (25%) primarily focused on the European region. Key lessons focused on organisational factors, diagnosis and detection, human resources, communication, accreditation, funding, and sustainability. Enablers and constraints were consistent across regions/ organisations. A clear understanding of the regional context, budgets, cultural or language issues, staffing capacity and governmental priorities, is pivotal. An initial workshop inclusive of the various bodies involved in the design, implementation, monitoring or evaluation of programmes is essential. Clear governance structure, with individual responsibilities clear from the beginning, will reduce friction. Secure, long-term funding is also a key aspect of the success of any programme. Conclusion: Operationalisation of regional infectious disease bodies and networks is complicated, but with extensive groundwork, and focus on organisational factors, diagnosis and detection, human resources, communication, accreditation, funding, and sustainability, it is achievable. Ways to promote success are to include as many stakeholders as possible from the beginning, to ensure that context-specific factors are considered, and to encourage employees through capacity building and mentoring, to ensure they feel valued and reduce staff turnover.

21 April 2020 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
NMNao Matsuo
Nao Matsuo
RNRina Nonogaki
Rina Nonogaki
MNMichiko Nagashima-Hayashi
Michiko Nagashima-Hayashi
JWJun-Ichi Wachino
Jun-Ichi Wachino
MSMasahiro Suzuki
Masahiro Suzuki
KKKumiko Kawamura
Kumiko Kawamura
We characterized 29 bla CTX-M-27 -harboring plasmids of Escherichia coli sequence type 131 (ST131) sublineage C1/ H 30R isolates from healthy individuals and long-term-care facility (LTCF) residents. Most (27/29) plasmids were of the FIA, FIB, and FII multireplicon type with the same plasmid multilocus sequence typing (pMLST). Several plasmids (7/23) from LTCF residents harbored only bla CTX-M-27 as the resistance gene; however, their fundamental structures were very similar to those of previously isolated bla CTX-M-27 /F1:A2:B20 plasmids, suggesting their prevalence as a newly arising public health concern.